The search for diagnostic and progression markers in AD: so near but still too far?

Editorial

S E Black. Neurology. 1999.

. 1999 May 12;52(8):1533-4.

doi: 10.1212/wnl.52.8.1533.

No abstract available

Comment on

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.
Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H. Hulstaert F, et al. Neurology. 1999 May 12;52(8):1555-62. doi: 10.1212/wnl.52.8.1555. Neurology. 1999. PMID: 10331678
Correlation between rates of brain atrophy and cognitive decline in AD.
Fox NC, Scahill RI, Crum WR, Rossor MN. Fox NC, et al. Neurology. 1999 May 12;52(8):1687-9. doi: 10.1212/wnl.52.8.1687. Neurology. 1999. PMID: 10331700